Gladys Ouédraogo

2.0k citations

25 papers · 781 indexed · h-index 14

Small Animals top 1%
- Animal testing and alternatives 16
Health, Toxicology and Mutagenesis top 5%
- Effects and risks of endocrine disrupting chemicals 16
Chemical Health and Safety top 10%
Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 12
Dermatology top 5%
Computational Theory and Mathematics
- Computational Drug Discovery Methods 3
Plant Science
- Pesticide Exposure and Toxicity 3
Immunology
- Immunotoxicology and immune responses 2
Molecular Biology
- Molecular Biology Techniques and Applications 2
Biomedical Engineering
- 3D Printing in Biomedical Research 2

Co-authors: Stefan Pfuhler Daniel Duché Avner Ehrlich Yaakov Nahmias Nicola J. Hewitt Kerstin Reisinger Julia Kenny Catherine Mahony
Cited by: Small Animals Health, Toxicology and Mutagenesis Chemical Health and Safety
Partner nations: France United Kingdom United States

In The Last Decade

Gladys Ouédraogo

23 papers receiving 761 citations

Peers

Countries citing papers authored by Gladys Ouédraogo

Since Specialization

Citations

This map shows the geographic impact of Gladys Ouédraogo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gladys Ouédraogo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gladys Ouédraogo more than expected).

Fields of papers citing papers by Gladys Ouédraogo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gladys Ouédraogo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gladys Ouédraogo. The network helps show where Gladys Ouédraogo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gladys Ouédraogo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gladys Ouédraogo Line = papers co-authored together Gladys Ouédraogo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A call to action: Advancing new approach methodologies (NAMs) in regulatory toxicology through a unified framework for validation and acceptance Gladys Ouédraogo,Nathalie Alépée,Barış Tan,Clive Roper	2025	0
2	New approach methodologies for evaluating developmental and reproductive toxicity potential: Review on state of the art, applicability for cosmetic related ingredients and coverage of developmental stages M. Burbank,N. Hewitt,F. Gautier,A. Noel-Voisin,N. Golbamaki,Romain Grall,Michael S. Leonard,Léopold Carron,A. Riu,Simon Emery,Ann Detroyer,T. Bringel,L. Guillet-Revol,N. De Croze,Gladys Ouédraogo	2025	0
3	In vitro pharmacologic profiling aids systemic toxicity assessment of chemicals Matthew J. Burbank,Predrag Kukić,Gladys Ouédraogo,J. Gerry Kenna,Nicola J. Hewitt,Duncan Armstrong,Annie Otto‐Bruc,Johanna Ebmeyer,M. Boettcher,Ian Willox,Catherine Mahony	2024	2
4	Advancing the use of new approach methodologies for assessing teratogenicity: Building a tiered approach M. Burbank,F. Gautier,Nicola J. Hewitt,Ann Detroyer,L. Guillet-Revol,Léopold Carron,T. Wildemann,T. Bringel,A. Riu,A. Noel-Voisin,N. De Croze,Martine Léonard,Gladys Ouédraogo	2023	11
5	Use of in vitro metabolism and biokinetics assays to refine predicted in vivo and in vitro internal exposure to the cosmetic ingredient, phenoxyethanol, for use in risk assessment Nicola J. Hewitt,John Troutman,Julia Przibilla,Andreas Schepky,Gladys Ouédraogo,Catherine Mahony,J. Gerry Kenna,Mustafa Varçin,M. Dent	2022	12
6	New framework for a non-animal approach adequately assures the safety of cosmetic ingredients – A case study on caffeine Dagmar Bury,Camilla Alexander‐White,Harvey J. Clewell,M Cronin,Bertrand Desprez,Ann Detroyer,Alina Efremenko,James W. Firman,Eric Hack,Nicola J. Hewitt,J. Gerry Kenna,Martina Klarić,Cathy Lester,Catherine Mahony,Gladys Ouédraogo,Alicia Paini,Andreas Schepky	2021	32
7	Use of in vitro 3D tissue models in genotoxicity testing: Strategic fit, validation status and way forward. Report of the working group from the 7th International Workshop on Genotoxicity Testing (IWGT) Stefan Pfuhler,Jan van Benthem,Rodger Curren,Shareen H. Doak,Mária Dušinská,Makoto Hayashi,Robert H. Heflich,Darren Kidd,David Kirkland,Yang Luan,Gladys Ouédraogo,Kerstin Reisinger,Toshio Sofuni,Frédérique van Acker,Ying Yang,Raffaella Corvi	2020	46
8	Validation of the 3D reconstructed human skin micronucleus (RSMN) assay: an animal-free alternative for following-up positive results from standardin vitrogenotoxicity assays Stefan Pfuhler,Thomas R. Downs,Nicola J. Hewitt,Sebastian Hoffmann,Greg C. Mun,Gladys Ouédraogo,Shambhu Roy,Rodger D. Curren,Marilyn J. Aardema	2020	19
9	Profiling 58 compounds including cosmetic-relevant chemicals using ToxRefDB and ToxCast Ly Pham,Lisa Truong,Gladys Ouédraogo,Sophie Loisel-Joubert,Matthew T. Martin,Katie Paul Friedman	2019	9
10	A mode-of-action ontology model for safety evaluation of chemicals: Outcome of a series of workshops on repeated dose toxicity Bertrand Desprez,Barbara Birk,Bas J. Blaauboer,Alan R. Boobis,Paul L. Carmichael,M Cronin,Richard Curie,George P. Daston,Bruno Hubesch,Paul Jennings,Martina Klarić,Dinant Kroese,Catherine Mahony,Gladys Ouédraogo,Aldert H. Piersma,Andrea-Nicole Richarz,Michael Schwarz,Jan van Benthem,Bob van de Water,Mathieu Vinken	2019	17
11	Challenges and Opportunities in the Design of Liver-on-Chip Microdevices Avner Ehrlich,Daniel Duché,Gladys Ouédraogo,Yaakov Nahmias	2019	96
12	Microphysiological flux balance platform unravels the dynamics of drug induced steatosis Avner Ehrlich,Sabina Tsytkin-Kirschenzweig,Konstantinos Ioannidis,Muneef Ayyash,Anne Riu,Reine Note,Gladys Ouédraogo,Jan Vanfleteren,Merav Cohen,Yaakov Nahmias	2018	30
13	A strategy for systemic toxicity assessment based on non-animal approaches: The Cosmetics Europe Long Range Science Strategy programme Bertrand Desprez,Matt Dent,Detlef Keller,Martina Klarić,Gladys Ouédraogo,Richard Cubberley,Hélène Duplan,Joan Eilstein,Corie A. Ellison,Sebastien Grégoire,Nicola J. Hewitt,Carine Jacques,Daniela Lange,Amy L. Roe,Helga Rothe,Bas J. Blaauboer,Andreas Schepky,Catherine Mahony	2018	42
14	Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates Lisa Truong,Gladys Ouédraogo,Ly Pham,Jacques Clouzeau,Sophie Loisel-Joubert,Delphine Blanchet,Hicham Noçairi,Woodrow Setzer,Richard Judson,Chris Grulke,Kamel Mansouri,Matthew T. Martin	2017	9
15	Ab initio chemical safety assessment: A workflow based on exposure considerations and non-animal methods Elisabet Berggren,Andrew White,Gladys Ouédraogo,Alicia Paini,Andrea-Nicole Richarz,Frédéric Y. Bois,Thomas E. Exner,Sofia Batista Leite,Leo A. van Grunsven,Andrew Worth,Catherine Mahony	2017	71
16	Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop David Kirkland,Errol Zeiger,Federica Madia,Nigel J. Gooderham,Peter Kasper,Anthony Lynch,Takeshi Morita,Gladys Ouédraogo,Juan Manuel Parra Morte,Stefan Pfuhler,Vera Rogiers,Markus Schulz,Véronique Thybaud,Jan van Benthem,Philippe Vanparys,Andrew Worth,Raffaella Corvi	2014	50
17	Use of Human In Vitro Skin Models for Accurate and Ethical Risk Assessment: Metabolic Considerations Nicola J. Hewitt,Robert J. Edwards,Ellen Fritsche,Carsten Goebel,Pierre Aeby,Julia Scheel,Kerstin Reisinger,Gladys Ouédraogo,Daniel Duché,Joan Eilstein,Alain Latil,Julia Kenny,Claire E. Moore,Jochen Kuehnl,José G. Barroso,Rolf Fautz,Stefan Pfuhler	2013	76
18	In vitro genotoxicity test approaches with better predictivity: Summary of an IWGT workshop Stefan Pfuhler,Mick D. Fellows,Jan van Benthem,Raffaella Corvi,Rodger Curren,Kerry L. Dearfield,Paul Fowler,Roland Frötschl,Azeddine Elhajouji,Ludovic Le Hégarat,Toshio Kasamatsu,Hajime Kojima,Gladys Ouédraogo,Andrew D. Scott,Günter Speit	2011	84
19	The reconstructed skin micronucleus assay (RSMN) in EpiDerm™: Detailed protocol and harmonized scoring atlas Erica L. Dahl,Rodger Curren,Brenda C. Barnett,Zubin S. Khambatta,Kerstin Reisinger,Gladys Ouédraogo,Brigitte Faquet,Anne-Claire Ginestet,Greg C. Mun,Nicola J. Hewitt,G.J. Carr,Stefan Pfuhler,Marilyn J. Aardema	2010	39
20	Animal-free genotoxicity testing: The COLIPA program Stefan Pfuhler,Paul L. Carmichael,Paul Fowler,Rodger Curren,Cyrille Krul,Gladys Ouédraogo,Kerstin Reisinger,Monique Marrec-Fairley,Annette Kirst,Nicola J. Hewitt	2010	1

About Gladys Ouédraogo

Gladys Ouédraogo is a scholar working on Small Animals, Health, Toxicology and Mutagenesis and Cancer Research, having authored 25 papers that have together received 781 indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (16 papers), Animal testing and alternatives (16 papers), Carcinogens and Genotoxicity Assessment (12 papers), Computational Drug Discovery Methods (3 papers), Pesticide Exposure and Toxicity (3 papers), Immunotoxicology and immune responses (2 papers), Molecular Biology Techniques and Applications (2 papers) and 3D Printing in Biomedical Research (2 papers). The work is most often cited by research in Small Animals (243 citations), Health, Toxicology and Mutagenesis (261 citations) and Chemical Health and Safety (11 citations). Gladys Ouédraogo has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Stefan Pfuhler, Daniel Duché, Avner Ehrlich, Yaakov Nahmias, Nicola J. Hewitt, Kerstin Reisinger, Julia Kenny, Catherine Mahony, Rodger Curren and Jan van Benthem.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact